*As of 2025.08.26 – PW may changed, please refer to the detailed program platform for an updated list
[POSTER 005] Spatially decoding cellular and molecular drivers of atopic dermatitis – A. Foster, United Kingdom
[POSTER 008] Development of a Humanized Mouse Model of Vitiligo – A. Gilhar, Israel
[POSTER 009] UVB Phototherapy Suppress Melanocyte Autoantigen Presentation by Downregulating HLA-C in Psoriasis – Y. Arakawa, Japan
[POSTER 011] Klk6-Par1-mediated KC-T cell interactions drive self-sustaining skin inflammation beyond psoriasis canonical cytokines – N.L. Ward, United States
[POSTER 017] Characterization and pharmacological inhibition of an adult antibody-transfer mouse model of pemphigus vulgaris – S. Emtenani, Germany
[POSTER 288] The Role and Mechanism of Olfactory Receptor OR6A2 in Mediating Immune-Inflammatory Responses through Sensing Skin Microbiota-Derived Volatile Organic Compounds (VOCs) in the Pathogenesis of Atopic Dermatitis – J. Yu, China
[POSTER 289] Sebum-induced type 17 inflammatory milieu underpins the body-site heterogeneity of atopic dermatitis – Z. Qiu, China
[POSTER 290] CD11c+ dendritic cell-derived HMGB1 induces RIPK3/MLKL-dependent keratinocyte necroptosis in the epidermis and triggers inflammatory lesion development in Steven-Johnson Syndrome and Toxic Epidermal Necrolysis. – M.C. Bonnet, France
[POSTER 297] Decoding plasmacytoid dendritic cells heterogeneity in inflammatory skin diseases and skin tumors – J. Di Domizio, Switzerland
[POSTER 298] Imaging mass cytometry to delineate the cutaneous immune cell landscape of pemphigus – R. Sia Zu Wern, United Kingdom
[POSTER 164] Rab27B GTPase regulates late steps of lamellar body trafficking – C. Leprince, France
[POSTER 165] A 3D Full-Thickness Human Skin Model of Atopic Dermatitis with Complex Microvasculature for Disease Modeling and Therapeutic Testing – M. DOS SANTOS, France
[POSTER 167] Dissimilar roles for papillary and reticular fibroblasts in skin barrier integrity: insights from in vitro 3D fibroblast-derived matrix models – A. Louis, Netherlands
[POSTER 168] Hair Follicle Biofilm: Reservoirs Driving Scalp Microbiome Balance and Dysbiosis – V. Rasheedkhan Regina, Singapore
[POSTER 171] H4K12 Lactylation Promotes Munro Microabscess Formation and Desquamation via CHST2-Enhanced Keratan Sulfate Electrostatic Binding with CXCL1/CXCL8 in Psoriasis – P. Zhu, China
[POSTER 172] TNF-α Promotes Psoriasis-Related Keratinocytes Dedifferentiation by Inactivating NOTCH1 Signaling – Z. Yu, China
[POSTER 173] Phosphoproteomic profiling of the epidermis to enhance skin adaptation to the exposome – N. Bechetoille, France
[POSTER 174] Epidermal TRPV4 Downregulation May Link Skin Barrier Dysfunction and Mechanical Itch in a Murine Model of Xerosis – R. Saito, Japan
[POSTER 175] Staphylococcus epidermidis Extracellular Cysteine Protease EcpA Alters the Response of Primary Human Keratinocytes to Ultraviolet Radiation – W. Duan, United Kingdom
[POSTER 176] Preclinical assessment of a CYP26B1 inhibitor for treating acne and keratinization disorders. – P. Diaz, United States
[POSTER 439] Gradients of Mesenchymal Stiffness Control Sweat Gland Cell Fate Specification During Morphogenesis- C. Lu, United States
[POSTER 442 ] Deciphering the role of keloid fibroblasts in itch – S. Limbu, United Kingdom
[POSTER 444 ] S100A8/A9 Induced Adaptive Response of Mesenchymal Stromal Cells – Y. Wang, Germany
[POSTER 445 ] CCL22-Mediated Th1 Cell Recruitment Drives IFN-γ–Induced Sweat Duct Injury in Acquired Idiopathic Generalized Anhidrosis (AIGA) – S. Takei, Japan
[POSTER 446 ] Induction of tissue-specific premature stem cell aging via dysregulation of Lef1-mediated DNA damage response promotes senescence-like phenotypes in remote multiple organs – Y. Ikuno, Japan
[POSTER 447 ] Skin-Associated Cartilage Consists of Lipid-Filled Cells That Modify Hair Growth via BMP and WNT Signaling – M. Plikus, United States
[POSTER 448 ] Combined therapeutic approach: Inhibition of MMP-9 and JAK Signaling Synergistically Prevents Depigmentation in Experimental Vitiligo – C. Drullion, France
[POSTER 449 ] Long-Term Role of Hair Follicle Stem Cells in Epidermal Wound Healing – E. Inamura, Japan
[POSTER 450 ] Exploring NFATC2 as a molecular link between polycyclic aromatic hydrocarbons and dysregulated skin pigmentation – R. Phua, Singapore
[POSTER 229 ] Genome-Wide Association Study of Skin Barrier Function in a Multi-Ethnic Southeast Asian Population Cohort indicates mechanistic link with asthma.- Y. Yew, Singapore
[POSTER 231 ] Genome-wide meta-analysis establishes the genetic basis of lichen sclerosus- N. Dand, United Kingdom
[POSTER 233] Pharmacological Targeting of Notch Pathway by Nirogacestat Counteracts Skin Fibrosis: New Evidence from Preclinical Models of Recessive Dystrophic Epidermolysis Bullosa – A. Condorelli, Italy
[POSTER 235 ] EGFR mediates ST18-induced acantholysis in PV – R. Ishtewy, Israel
[POSTER 237 ] Proteomic and Functional Characterization of XP-C Melanocytes Reveals Interferon-mediated Inflammatory and Tumorigenic Signaling – Z. EL DOR, France
[POSTER 238 ] Functional genomics in psoriasis: correlation between the presence of SNP in the HLA-C gene upstream region and biogenesis of regulatory lncRNAs – V. Di Francesco, Italy
[POSTER 239 ] Elucidating the Molecular Basis of Solitary Lesion Formation in Porokeratosis of Mibelli – A. Kubo, Japan
[POSTER 240 ] Digenic inheritance of SERPINA12 and SERPINB7 in Nagashima-type palmoplantar keratoderma, prevalent pEDD in East Asia – A. Ebata, Japan
[POSTER 241 ] miR-382-5p promotes skin aging via SLC26A3-mediated suppression of SIRT6 and extracellular matrix degradation – D. Lee, South Korea
[POSTER 246] Promising efficacy of LIMK inhibitors in reducing cutaneous neurofibromas in an Nf1-KO mice – L. Fertitta, France
[POSTER 018] Impact Of Tralokinumab On Circulating And Skin Immune Cell landscape In Patients With Atopic Dermatitis – M. Starrenburg, Netherlands
[POSTER 020] Galvokimig, a multispecific antibody–based therapeutic, for the treatment of inflammatory skin diseases associated with both type 2 and type 3 inflammation – S. Stanyon, United Kingdom
[POSTER 022] DPP4 and its inhibition has no impact on disease progression and severity in a bullous pemphigoid like mouse model – J. Im, Germany
[POSTER 023] Down-regulated AhR expression fuels an IFN-γ-high, checkpoint-low immune phenotype in vitiligo and is reversible by the AhR agonist tapinarof – A. Belpaire, Belgium
[POSTER 024] Prevalence and pathogenicity of anti-SPCA1 and anti-M3AchR auto-antibodies in pemphigus – P. Joly, France
[POSTER 301] Proteomic analysis of non-segmental vitiligo identifies alterations in immune regulation – M.B. Haulrig, Denmark
[POSTER 302] Distinct molecular profiles in hard-to-treat versus classical psoriasis: a proteomic analysis – H. Lee, Germany
[POSTER 304] Multiomics analysis of NK cells identifies potenital epigenetic mechanisms in NK genes as therapeutic candidates in Asian Atopic Dermatitis – A. Andiappan, Singapore
[POSTER 305] The Matricellular Protein Mindin Regulates Differential Fibroblast Responses to Manifest Dermal Fibrosis in Scleroderma – G.P. Kansagara, India
[POSTER 307] Phototherapy-induced beta-defensin 1 suppresses inflammation in atopic dermatitis via LYVE1+ Macrophages – A. . Joshi, Austria
[POSTER 088] Use of antidiabetic medications and risk of basal cell carcinoma – H. Kuru, Finland
[POSTER 089]Results of the clinical study Aprepitant versus HYdroxyzine in combination with cytoreductive therapy for patients with myeloproliferative neoplasms suffering from Persistent Aquagenic Pruritus (APHYPAP) – C. LE GALL-IANOTTO, France
[POSTER 091] Icotrokinra, a targeted oral peptide that selectively blocks the interleukin-23–receptor, for the treatment of moderate-to-severe plaque psoriasis: Results through Week 24 of the Phase 3, randomized, double-blind, placebo-controlled ICONIC-LEAD trial – J. Obeid, United States
[POSTER 093] A phenotypic-genotypic observational analysis of the International dystrophic epidermolysis bullosa registry – A. Agrawal, India
[POSTER 094] Reduced prefrontal cortex-precuneus functional connectivity in females with atopic dermatitis: A resting-state functional magnetic resonance imaging study. – T. Jonsson, Sweden
[POSTER 096] Treat-to-Target Outcomes With ESK-001 in Moderate-to-Severe Plaque Psoriasis: Results From the Phase 2 STRIDE & Open-Label Extension Studies – Y. Klyachkin, United States
[POSTER 097] Phase 3 results from an innovative trial design of treating plaque psoriasis involving difficult-to-treat, high-impact sites with icotrokinra, a targeted oral peptide that selectively inhibits the IL-23–receptor – J. Obeid, United States
[POSTER 098] Assessing genotypic, phenotypic, and polygenic risk associations of autoimmune comorbidities in FinnGen patients with vitiligo – S. Chen, France
[POSTER 494] PHLDA3 as a regulator of cell proliferation and its potential role in keloids – M. Li, Japan
[POSTER 495] Topical treatment with TCP-25, a novel immunomodulatory peptide, in epidermolysis bullosa: a phase I study – K. Holmgren, Sweden
[POSTER 497] Extracellular matrix composition directs Schwann cell behaviour in wound healing – M. Bucekova, Austria
[POSTER 498] HDACs regulate skin fibroblast lineage commitment and fibrosis – S. zhu, Austria
[POSTER 499] Keratinocyte heterogeneity and dynamics in a human skin wound healing ex vivo model – J. Lee, United Kingdom
[POSTER 500] The urokinase inhibitor BC-11 attenuates skin fibrosis via macrophage-fibroblast crosstalk modulation – L. Auer, Austria
[POSTER 501] Boosting efferocytosis and messages from inflammatory death aid in tissue recovery and wound healing. – S. Maschalidi, Belgium
[POSTER 502] Cross-linked fibrin fragment (X-FIB) as a biomarker for endotype differentiation and response to omalizumab treatment in chronic spontaneous urticaria – H. Port Linares, Denmark
[POSTER 503] Impact of mitochondrial damage on dermal fibroblast function and fibrotic development – J. Nätlitz, Germany
[POSTER 504] Hair follicle transplantation for hard to heal wounds: In vivo reflectance confocal microscopy asessment of skin regeneration – A. Altinova, Germany
[POSTER 177] Transglutaminase 2 deficient sebocytes display disturbed autophagy and lipid secretion A. Stiegler, Austria
[POSTER 178] Comparative transcriptomics reveals evolutionarily conserved roles of the epidermal differentiation complex in the skin and the esophagus – L. Eckhart, Austria
[POSTER 179] Senescent melanocytes impair skin barrier function – H. Kang, South Korea
[POSTER 180] EcpA-Mediated Skin Protein Degradation by Staphylococcus epidermidis in Atopic Dermatitis – V. Patra, France
[POSTER 181] Skin insulin resistance as an initiator of diabetes-associated barrier dysfunction and systemic insulin insensitivity – L. Trojahn, Germany
[POSTER 182] TMEM99 is a long non-coding RNA induced during keratinocyte differentiation – E. Kelemen, Hungary
[POSTER 183] Investigation of Desmoglein-1 Glycation in Human Skin: Underlying Factor Relating to Impairment of Desquamation – M.H. Fujii, Japan
[POSTER 184] Solar Simulated Radiation Alters the Tryptophan Metabolism and Barrier-Modulating Properties of Skin Commensal Bacteria – S. Mercer, United Kingdom
[POSTER 185] Inhibition of mechanistic target of rapamycin (mTORC1) signalling by Lactobacillus rhamnosis GG in human keratinocytes – L. Coppock, United Kingdom
[POSTER 190] Improving Atopic Dermatitis management with advanced hydrogels: insights from 3D-epidermal skin models – A.F. Barbosa, Portugal
[POSTER 025] Oral epithelial cells contribute to the interferon response in Oral Lichen Planus- S.V. Wagle, Germany
[POSTER 026] PI3K inhibitors may be potential therapeutic agents for psoriasis – K. Nakajima, Japan
[POSTER 027] Impact of dupilumab and upadacitinib on epigenetic and transcriptomic changes in skin-homing T cells in atopic dermatitis – H. Smits, Netherlands
[POSTER 028] Transcriptomic profiling of hyperkeratotic hand eczema skin with comparison to atopic dermatitis and psoriasis – W. Zhou, Netherlands
[POSTER 032] LC-OCT Characterization of Senescence-Associated Dermal Alterations and Adnexal Remodeling in Vitiligo-Affected Skin – A. Paganelli, Italy
[POSTER 308] Cell atlas of palmoplantar pustulosis reveals inflammation-associated fibroblast populations – Y. Zheng, China
[POSTER 309] Loss of CD103 reduces chronic inflammation by decreasing the retention of IL-17a-secreting γδTcells – L. Ye, China
[POSTER 310] Tapinarof alleviates atopic dermatitis via metabolic-epigenetic crosstalk regulating histone lactylation in keratinocytes – Y. Zhao, China
[POSTER 311] Role of oncostatin M in a chronic mouse model of psoriasis – C. Dumonteix Moreau, France
[POSTER 318] Inhibition of HuR/Elavl1 activity in human primary keratinocytes and T cells as a new therapeutic strategy for psoriasis – R. Lotti, Italy
[POSTER 388] Immunomodulatory functions of cancer-associated fibroblasts in melanoma- D. Kholodniuk, Austria
[POSTER 389] Receptor-interacting protein kinase 4 as a tumor suppressor of skin carcinogenesis – B. Stepic, Belgium
[POSTER 390] C3a/C3aR1 axis promotes invasion of cutaneous squamous cell carcinoma- L. Heiskanen, Finland
[POSTER 394] Effectiveness of iPS cell-derived proliferating myeloid cells, a new cell therapy, in a mouse subcutaneous melanoma model – Y. Ichigozaki, Japan
[POSTER 395] Spatial transcriptomic profiling outlines the evolution of molecular trajectories across different stages of cutaneous squamous cell carcinoma – F. Naji, France
[POSTER 396] Spatially dissecting the role of macrophages in cutaneous lymphoma – B. Fischer, Sweden
[POSTER 397] A Novel Fisetin Analog, F20, Enhances Vemurafenib Efficacy and Inhibits Tumor Growth in a BRAF-Mutant Melanoma Xenograft Model- J. Chamcheu, United States
[POSTER 398] Endothelial Progenitor Plasticity as a Driver of Immune Suppression in Melanoma – L. Sormani, Australia
[POSTER 400] Overcoming resistance to immune-checkpoint blockade due to deficient antigen presentation in melanoma using in vivo CRISPR screens – A.I. Lakatos, Hungary
[POSTER 401] Eribulin has anti-tumor activity in two novel preclinical models of Merkel cell carcinoma – K. Miyamoto, Japan
[POSTER 242 ] Cutaneous ubiquitinome profiling
identifies ubiquitin dependent processes in healthy skin and CYLD
deficient tumours – J. Inns, United Kingdom
[POSTER 243] IL-1 Signaling Blockade Mitigates Inflammation and Improves Survival in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa – R. Hirani, United States
[POSTER 244] A human epidermal model of keratin 5 loss-of-function reveals potential therapeutic strategies for epidermolysis bullosa simplex – C.L. Simpson, United States
[POSTER 245] Modeling Pigmentary Abnormalities of XP-C Disease using 3D Reconstructed Skin Organoids Reveals a Potent Correlation between XPC and Pigmentation. – J. El Mir, France
[POSTER 247] Lipid nanoparticles as mRNA delivery vehicles for the treatment of dystrophic epidermolysis bullosa – I. Guri, United Kingdom
[POSTER 248] Exploring the Effect of Skin Ageing-Related Basement Membrane Collagen Loss on Nuclear Mechanics – S.K. Summan, United Kingdom
[POSTER 249] Imsidolimab a novel high affinity IgG4 IL36 Receptor Antagonist was Effective and Well Tolerated in Patients with GPP – S. Smieszek, United States
[POSTER 250] Histone Deacetylase 3 Drives Recessive Dystrophic Epidermolysis Bullosa Fibroblasts Towards an Anti-Fibrotic Phenotype – C. Sanjeevamurthy, Italy
[POSTER 251] Understanding the early origins of Steatocystoma Multiplex – M. de Brito, United Kingdom
[POSTER 261] Readthrough therapy for CYLD Cutaneous Syndrome (CCS): A screening strategy for assessing premature termination codon readthrough compounds. – A. Hajdu, Hungary
[POSTER 451] Targeting Melanocyte Stem Cell Activation for Improved Phototherapy Outcomes in Vitiligo – G. Goh, Singapore
[POSTER 452] Mast cell-linked molecular signatures in syringoma identified by spatial transcriptomic approaches – S. Cho, South Korea
[POSTER 453] Signaling by Senescent Melanocytes Induces New Hair Growth and Informs Hair Growth-Activating Injectable for Androgenetic Alopecia – M. Plikus, United States
[POSTER 454] Modeling epidermolysis bullosa simplex with cardiomyopathy using KLHL24-mutant pluripotent stem cells. – K. Raymond, Netherlands
[POSTER 457] Impact of alpha-melanocyte-stimulating hormone on mitochondrial function in human dermal fibroblasts – D. Flis, Poland
[POSTER 506] Activation of the α7 nicotinic acetylcholine receptor attenuates fibrotic endothelial to mesenchymal transition – A. Stegemann, Germany
[POSTER 507] Investigation of mechanically induced cellular responses in human dermal fibroblasts – E. Lisztes, Hungary
[POSTER 508] Preclinical evidence that mesoglycan unfolds complex anti-aging effects in photoaged female facial skin – A. Gilhar, Israel
[POSTER 509] A pseudo-angiogenic fibroblast gene expression signature and macrophage skewing in hypertrophic scars. – R. O’Shaughnessy, United Kingdom
[POSTER 513] Role of burn blister fluid in human skin wound healing – M. Pipelzadeh, Iran
[POSTER 312] Bioengineering of a Full-Thickness Human 3D Skin Equivalent Including Hypodermis and an Immunocompetent Epidermis for Studies of Skin Physiology and Inflammation – M. Dos Santos, France
[POSTER 313] PA2G4 mediates keratinocyte proliferation and cell death – T. Raunegger, Germany
[POSTER 314] Separation of innate from adaptive immunity by the transcription factor ATF3 – A.S. Ya, Germany
[POSTER 315] Butyrophilin-like 2 (BTNL2) controls auto-aggressive dermal γδT lymphocytes that attack human hair follicles. – J. Gherardini, Germany
[POSTER 316] Psoriatic fibroblasts exhibit a distinct transcriptomic profile – L.B. Flink, Hungary
[POSTER 317] Targeting neurogenic skin inflammation mitigates stress-exacerbated psoriasis: Insights from a stress-responsive “humanized” psoriasis mouse model – A. Gilhar, Israel
[POSTER 319] Investigating the adhesion of Staphylococcus epidermidis to corneocytes in atopic dermatitis – E.K. Simpson, United Kingdom
[POSTER 321] Zasocitinib-induced modulation of tyrosine kinase 2 signalling biomarkers is associated with treatment response in patients with moderate-to-severe plaque psoriasis – A. Choudhury, United States
[POSTER 323] Immune Cell Necroptosis Restrains Cutaneous Inflammation: Implications for Therapeutic Targeting – H. Anderton, Australia
[POSTER 030]Impaired Glutathione Synthesis in Hair Follicle Stem Cell Niches in Alopecia Areata – R. Mahon, United Kingdom
[POSTER 031] Spatial Transcriptomic Mapping of Dermatomyositis-Associated Calcinosis Cutis Reveals Local Professional Antigen Presentation, Plasma Cell Activation, and Acellular Calcinosis mRNA Signature – C. Parks, United States
[POSTER 033] Revealing Diverse Immune Endotypes in Japanese Patients with Inflammatory Skin Diseases: A Comprehensive Transcriptomic Approach- M. Uchibayashi, Japan
[POSTER 034] Paradoxical reactions – Cytokine imbalance during targeted therapies for psoriasis and atopic eczema – T. Caplanusi, Switzerland
[POSTER 042] Characterization of Pathogenic CD8+ T Cells in an adoptive transfer Mouse Model of Alopecia Areata in C3H/HeJ mice – S. Lavilla-Alonso, Spain
[POSTER 044] Circulating CD4+ Naïve and CLA+ T cells from atopic dermatitis and psoriasis patients exhibit dysregulated JAK-STAT signaling – M. Pook, Estonia
[POSTER 330] Z-DNA binding protein 1 as a nucleic acid sensor in keratinocytes: expression and splice variant diversity – J. Danis, Hungary
[POSTER 343] Extracellular Vesicles Released from Skin Keratinocytes in Response to Contact Allergens – J.L. Wong, Ireland
[POSTER 347] Site-specific differences in psoriatic skin transcriptome obtained with tape-stripping technique – M. Marovt, Slovenia
[POSTER 099] Decoding Immune Heterogeneity Underpinning Clinico-Pathological Features of Papuloerythroderma of Ofuji – K. Kataoka, Japan
[POSTER 101] Comparative genetic analysis of atopic dermatitis and psoriasis and the potential therapeutic implications – K. Watts, United Kingdom
[POSTER 102] A cohort study on recurrent serious infection risk with systemic treatments for psoriasis – H. Bright, United Kingdom
[POSTER 103] The aryl hydrocarbon receptor pathway is dysregulated in atopic dermatitis – H. Dawe, United Kingdom
[POSTER 105] HLA-C*06:02 is associated with response to IL-23-targeting biologic therapies in psoriasis – J. Saklatvala, United Kingdom
[POSTER 110] Non-tubercular mycobacterial skin and soft tissue infections in northern India – P. Jain, India
[POSTER 121] Quality of life in Bulgarian patients with autoimmune blistering diseases: ABQOL & TABQOL validation – D. Krastev, Bulgaria
[POSTER 104] Predicting probability of psoriasis biologic drug continuation: an explainable machine learning approach applying real-world data – A. Hussain, United Kingdom
[POSTER LB073] Identifying the severe psoriasis at-risk population: development of an integrated psoriasis severity risk stratification tool – M.K Sagoo, United Kingdom
[POSTER LB001] Developing a chronic spontaneous urticaria model in human skin explants – N. Hawkshaw, United Kingdom
[POSTER LB005] Integrated Multi-Omic Profiling of Cutaneous Squamous Cell Carcinoma in Recessive Dystrophic Epidermolysis Bullosa Identifies Targets for Therapeutic Repurposing – L. Marchal, France
[POSTER LB013] Deriving keratinocytes from iPSC to model epidermal differentiation and inflammatory skin diseases – L. Meesters, The Netherlands
[POSTER LB034] Investigation of the expression and role of TRPM2 ion channel in human sebocytes, A. Oláh Hungary
[POSTER LB035] HLA-ligand mapping reveals an expanded antigenic landscape in psoriatic skin – B. Kromann, Denmark
[POSTER LB037] Identification of PACAP-VIPR1 as a novel neuroimmune axis regulating human epidermal differentiation – K. Koshida, Japan
[POSTER LB040] Oily Skin, Metabolites and Microbes: An Integrated Look at Facial Skin Features – B. De Pessemier, Belgium
[POSTER LB046] Single-Cell RNA Sequencing Reveals Keratinocyte Dysfunction and Impaired Macrophage Phagocytosis Driven by Th2-Type Inflammation in Primary Cutaneous Amyloidosis – W. He, China
